Timothy R Donahue

6PUBLICATIONS
58CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 03, 2023
Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-Drug Conjugate for Treatment of CLDN18.2-Positive Cancers.

Neil A O'Brien, Martina S J McDermott, Jun Zhang

|May 17, 2023
MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling.

Razmik Ghukasyan, Keke Liang, Kevin Chau

|Mar 01, 2023
Higher Numbers of Examined Lymph Nodes Are Associated with Increased Survival in Resected, Treatment-Naïve, Node-Positive Esophageal, Gastric, Pancreatic, and Colon Cancers.

Razmik Ghukasyan, Sudeep Banerjee, Christopher Childers

|Dec 06, 2022
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer.

Samantha B Kemp, Noah Cheng, Nune Markosyan

|Mar 21, 2022
Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic Cancer.

Kristina Y Aguilera, Thuc Le, Rana Riahi

Pageof 1